186 related articles for article (PubMed ID: 34137023)
1. British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes.
Killick SB; Wiseman DH; Quek L; Cargo C; Culligan D; Enright H; Green S; Ingram W; Jones GL; Kell J; Krishnamurthy P; Kulasekararaj A; Mills J; Mufti G; Payne EM; Raghavan M; Stanworth SJ; Sternberg A; Bowen D;
Br J Haematol; 2021 Jul; 194(2):282-293. PubMed ID: 34137023
[No Abstract] [Full Text] [Related]
2. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
Schratz KE; DeZern AE
Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
[TBL] [Abstract][Full Text] [Related]
3. Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges.
Caponetti GC; Bagg A
Int J Lab Hematol; 2020 Dec; 42(6):671-684. PubMed ID: 32757473
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition to MDS: diagnosis and management.
Furutani E; Shimamura A
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):110-119. PubMed ID: 31808839
[TBL] [Abstract][Full Text] [Related]
5. Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis.
El Hussein S; Loghavi S
Clin Lab Med; 2023 Sep; 43(3):411-426. PubMed ID: 37481320
[TBL] [Abstract][Full Text] [Related]
6. Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?
Calvete O; Mestre J; Durmaz A; Gurnari C; Maciejewski JP; Solé F
Br J Haematol; 2023 Apr; 201(1):e5-e11. PubMed ID: 36717968
[No Abstract] [Full Text] [Related]
7. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients.
Kern W; Bacher U; Haferlach C; Alpermann T; Schnittger S; Haferlach T
Cytometry B Clin Cytom; 2015; 88(3):154-64. PubMed ID: 25581461
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
[TBL] [Abstract][Full Text] [Related]
9. Standardizing the initial evaluation for myelodysplastic syndromes.
Marshall D; Roboz GJ
Curr Hematol Malig Rep; 2013 Dec; 8(4):361-9. PubMed ID: 24178514
[TBL] [Abstract][Full Text] [Related]
10. Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes.
Padron E; Ball MC; Teer JK; Painter JS; Yoder SJ; Zhang C; Zhang L; Moscinski LC; Rollison DE; Gore SD; Bejar R; Walter MJ; Sekeres MA; Komrokji RS; Epling-Burnette PK
Blood; 2018 May; 131(21):2402-2405. PubMed ID: 29661788
[No Abstract] [Full Text] [Related]
11. Updates in cytogenetics and molecular markers in MDS.
Tiu RV; Visconte V; Traina F; Schwandt A; Maciejewski JP
Curr Hematol Malig Rep; 2011 Jun; 6(2):126-35. PubMed ID: 21340513
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.
Kawata E; Lazo-Langner A; Xenocostas A; Hsia CC; Howson-Jan K; Deotare U; Saini L; Yang P; Broadbent R; Levy M; Howlett C; Stuart A; Kerkhof J; Santos S; Lin H; Sadikovic B; Chin-Yee I
Br J Haematol; 2021 Feb; 192(4):729-736. PubMed ID: 32588428
[TBL] [Abstract][Full Text] [Related]
13. Pediatric myelodysplastic syndromes.
Rytting ME
Curr Hematol Rep; 2004 May; 3(3):173-7. PubMed ID: 15087064
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to MDS: clinical features and clonal evolution.
Kennedy AL; Shimamura A
Blood; 2019 Mar; 133(10):1071-1085. PubMed ID: 30670445
[TBL] [Abstract][Full Text] [Related]
15. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
[TBL] [Abstract][Full Text] [Related]
16. Overview of myelodysplastic syndromes.
Beris P; Georgiou G
Semin Hematol; 2012 Oct; 49(4):287-94. PubMed ID: 23079058
[TBL] [Abstract][Full Text] [Related]
17. [Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes].
Raynaud SD
Pathol Biol (Paris); 2003 Aug; 51(6):346-55. PubMed ID: 12927892
[TBL] [Abstract][Full Text] [Related]
18. The current approach to the diagnosis of myelodysplastic syndromes
Weinberg OK; Hasserjian RP
Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
Greenberg PL; Stone RM; Al-Kali A; Bennett JM; Borate U; Brunner AM; Chai-Ho W; Curtin P; de Castro CM; Deeg HJ; DeZern AE; Dinner S; Foucar C; Gaensler K; Garcia-Manero G; Griffiths EA; Head D; Jonas BA; Keel S; Madanat Y; Maness LJ; Mangan J; McCurdy S; McMahon C; Patel B; Reddy VV; Sallman DA; Shallis R; Shami PJ; Thota S; Varshavsky-Yanovsky AN; Westervelt P; Hollinger E; Shead DA; Hochstetler C
J Natl Compr Canc Netw; 2022 Feb; 20(2):106-117. PubMed ID: 35130502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
